Medtronic

Global Diabetes Care Devices Market Analysis/Forecasts Report 2022: A $42 Billion Market by 2028 - Rapid Technological Advancements in Diabetes Care Devices - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

However, the high cost of diabetes care devices is hampering the global diabetes care devices market growth

Key Points: 
  • However, the high cost of diabetes care devices is hampering the global diabetes care devices market growth
    Technological advancements in the healthcare industry are encouraging market players to focus on research and development of insulin delivery devices.
  • The continuous research in insulin pens supports the growth of the global diabetes care devices market during the forecast period.
  • The diabetes care devices allow diabetes patients to monitor and manage their diabetes in their homes.
  • The prevalence of type 1 diabetes patients is likely to fuel the demand for diabetes care devices.

Global Home Medical Equipment (HME) Market and Technology Report 2022: Market Revenue for 2020 and 2021, Estimates for 2022, and CAGR Projections Through 2027

Retrieved on: 
Friday, September 23, 2022

DUBLIN, Sept. 23, 2022 /PRNewswire/ --The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 23, 2022 /PRNewswire/ --The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the global market for home medical equipment.
  • Among the various diseases managed or treated with HME, diabetes accounted for the largest share of the global HME market in 2021.
  • The increasing prevalence of respiratory diseases, diabetes, sleep disorders, hypertension and a rapidly expanding senior population are pushing the growth of the global home medical equipment market.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Medtronic and Palantir and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, September 22, 2022

Medtronic is currently seeking regulatory approval for the MiniMed 780G model, which uses an advanced hybrid closed loop system.

Key Points: 
  • Medtronic is currently seeking regulatory approval for the MiniMed 780G model, which uses an advanced hybrid closed loop system.
  • Despite these serious issues with the 600 series, Medtronic assured investors that they expected the MiniMed 780G to drive growth.
  • Consistent with these optimistic statements, Medtronic again assured investors that FDA approval of the MiniMed 780G was imminent.
  • For more information on the Palantir class action go to: https://bespc.com/cases/PLTR
    About Bragar Eagel & Squire, P.C.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medtronic Plc - MDT

Retrieved on: 
Wednesday, September 21, 2022

NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (Medtronic or the Company) (NYSE:MDT).

Key Points: 
  • NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (Medtronic or the Company) (NYSE:MDT).
  • The investigation concerns whether Medtronic and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On December 15, 2021, Medtronic disclosed receipt of a warning letter from the U.S. Food and Drug Administration (FDA) regarding its Northridge, California facility (the Warning Letter).
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

ROSEN, A TOP RANKED FIRM, Encourages Medtronic plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDT

Retrieved on: 
Wednesday, September 21, 2022

WHAT TO DO NEXT: To join the Medtronic class action, go to https://rosenlegal.com/submit-form/?case_id=8603 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Medtronic class action, go to https://rosenlegal.com/submit-form/?case_id=8603 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Colle McVoy Accelerates Agency Transformation and Growth by Joining Stagwell's Constellation

Retrieved on: 
Wednesday, September 21, 2022

MINNEAPOLIS, Sept. 21, 2022 /PRNewswire/ -- Colle McVoy takes a pivotal step in building the agency of the future by joining Stagwell's (NASDAQ: STGW) powerhouse Constellation collective of best-in-class agencies. The Minneapolis full-service, creative agency joins 72andSunny, Brand Citizens, Harris Poll, Hecho Studios, Instrument, Redscout and TEAM Enterprises to bring the power of their collective mastery to organize into bespoke solutions to solve the toughest business problems.

Key Points: 
  • MINNEAPOLIS, Sept. 21, 2022 /PRNewswire/ -- Colle McVoy takes a pivotal step in building the agency of the future by joining Stagwell's (NASDAQ: STGW)powerhouse Constellation collective of best-in-class agencies.
  • Created in 2020, Constellation is a formation of agencies withinStagwell across marketing services, including data, insights, creativity, technology and experiential.
  • "Joining Constellation is an evolution of our journey to expand our array of capabilities to fuel our clients' and agency growth,"said Christine Fruechte, CEO of Colle McVoy and its branded practices 10 Thousand Design and Exponent PR.
  • Colle McVoy is a full-service creative agency that leads brands to their next.

Investor Alert: Medtronic plc (MDT) Class Action - Bronstein, Gewirtz & Grossman, LLC, A Prominent Firm, Encourages Shareholders to Actively Participate

Retrieved on: 
Wednesday, September 21, 2022

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

Key Points: 
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • If you suffered a loss in Medtronic you have until November 7, 2022 to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

Medtronic announces closing of public offering of €3.5 billion of senior notes

Retrieved on: 
Wednesday, September 21, 2022

( "Medtronic Luxco") has closed a registered public offering (the "Offering") of 500,000,000 principal amount of 2.625% Senior Notes due 2025, 1,000,000,000 principal amount of 3.000% Senior Notes due 2028, 1,000,000,000 principal amount of 3.125% Senior Notes due 2031 and 1,000,000,000 principal amount of 3.375% Senior Notes due 2034 (collectively, the "Notes").

Key Points: 
  • ( "Medtronic Luxco") has closed a registered public offering (the "Offering") of 500,000,000 principal amount of 2.625% Senior Notes due 2025, 1,000,000,000 principal amount of 3.000% Senior Notes due 2028, 1,000,000,000 principal amount of 3.125% Senior Notes due 2031 and 1,000,000,000 principal amount of 3.375% Senior Notes due 2034 (collectively, the "Notes").
  • All of Medtronic Luxco's obligations under the Notes are fully and unconditionally guaranteed by the Company and Medtronic, Inc., a wholly-owned indirect subsidiary of Medtronic Luxco, on a senior unsecured basis.
  • The net proceeds from the Offering are approximately 3.47 billion, after deducting underwriting discounts and commissions and estimated expenses related to the Offering payable by Medtronic Luxco.
  • The net proceeds of the Offering are expected to be used to repay at maturity Medtronic Luxco's outstanding 0.00% Senior Notes due 2022, 0.375% Senior Notes due 2023 and 0.00% Senior Notes due 2023 and for general corporate purposes.

MEDTRONIC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Medtronic plc - MDT

Retrieved on: 
Wednesday, September 21, 2022

This action is pending in the United States District Court for the District of Minnesota.

Key Points: 
  • This action is pending in the United States District Court for the District of Minnesota.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 7, 2022.
  • Medtronic and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.

Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation

Retrieved on: 
Tuesday, September 20, 2022

I am confident in NPS technology and its potential, said Robert Duggan, Executive Chairman of Pulse Biosciences.

Key Points: 
  • I am confident in NPS technology and its potential, said Robert Duggan, Executive Chairman of Pulse Biosciences.
  • Implementing the present time strategic opportunities does not require the significant sales, marketing and related administrative support team that has been in place.
  • Accordingly, headcount now stands at 66 employees principally focused on engineering, business development and related new product support personnel.
  • Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.